NCT04458883 The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field
| NCT ID | NCT04458883 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Aberdeen |
| Condition | Myocardial Infarction |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2020-08-01 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2020-08-01 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main aim of the study is to build and test a cardiac-specific coil purposely assembled in house to suit the FFC-MRI whole-body prototype and to test if it could be used for clinical cardiac scans in human subject populations.
Eligibility Criteria
Inclusion Criteria: * Participant who is willing and able to give informed consent for participation in the study * Healthy volunteers willing to give informed consent for participation in the study * Patients diagnosed with a previous myocardial infarction Exclusion Criteria: * Unwillingness to participate * Claustrophobia * Contraindication to MRI scanning such as implantable cardiac devices * Participants who have had a previous myocardial infarction in the past of which they may not be aware and this is discovered whilst being scanned on the 3T MRI scanner, or who may have any other cardiology condition that they were previously unaware will not be included in the healthy control group, even if they present themselves to us as "healthy" at the time of the study visit * Pregnancy * Body habitus that may preclude comfortable positioning of the volunteer in either of the MRI scanners (\>50cm in diameter) * Participants with abnormal kidney function that will preclude them from receiving a contrast agent
Contact & Investigator
Dana Dawson, DPhil
PRINCIPAL INVESTIGATOR
University of Aberdeen
Frequently Asked Questions
Who can join the NCT04458883 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04458883 currently recruiting?
Yes, NCT04458883 is actively recruiting participants. Contact the research team at james.ross@abdn.ac.uk for enrollment information.
Where is the NCT04458883 trial being conducted?
This trial is being conducted at Aberdeen, United Kingdom, Aberdeen, United Kingdom.
Who is sponsoring the NCT04458883 clinical trial?
NCT04458883 is sponsored by University of Aberdeen. The principal investigator is Dana Dawson, DPhil at University of Aberdeen. The trial plans to enroll 150 participants.